Armata Pharmaceuticals (ARMP) EBT Margin (2016 - 2020)
Quarterly results put EBT Margin at 15193.55% for Q2 2020, changed N/A from a year ago — trailing twelve months through Jun 2020 was 18229.91% (changed N/A YoY), and the annual figure for FY2017 was 6029.57%, down 358418.0%.
Armata Pharmaceuticals has reported EBT Margin over the past 6 years, most recently at 15193.55% for Q2 2020.
- EBT Margin reached 15193.55% in Q2 2020 per ARMP's latest filing, down from 24270.0% in the prior quarter.
- Across five years, EBT Margin topped out at 24270.0% in Q4 2017 and bottomed at 27725.0% in Q2 2017.
- Median EBT Margin over the past 3 years was 4262.26% (2016), compared with a mean of 3881.12%.
- The largest annual shift saw EBT Margin skyrocketed 1584233bps in 2016 before it crashed -2398617bps in 2017.
- Over 3 years, EBT Margin stood at 13545.45% in 2016, then skyrocketed by 79bps to 24270.0% in 2017, then tumbled by -163bps to 15193.55% in 2020.
- Business Quant data shows EBT Margin for ARMP at 15193.55% in Q2 2020, 24270.0% in Q4 2017, and 2050.0% in Q3 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 41.95% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 23.05% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 18.99% |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -15,193.55% |
| Dec 31, 2017 | 24,270.00% |
| Sep 30, 2017 | -2,050.00% |
| Jun 30, 2017 | -27,725.00% |
| Mar 31, 2017 | -11,586.21% |
| Dec 31, 2016 | 13,545.45% |
| Sep 30, 2016 | -8,189.66% |
| Jun 30, 2016 | -3,738.83% |